Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.058 | 0.2 |